KCM
OLMA icon

Kingdon Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Kingdon Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-250,000
Closed -$3.51M – 98
2023
Q4 		$3.51M Buy
250,000
+151,400
+154% +$2.03M 0.44% 62
2023
Q3 		$1.22M Buy
+98,600
New +$1.01M 0.14% 69

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Kingdon Capital Management's OLMA Position: Q2 2026 in Review

Kingdon Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 40% in Q2 2026, buying an estimated $4.62M and bringing the position to 1,200,000 shares worth $15M. The position accounts for 1.54% of the portfolio, ranked #21.

Kingdon Capital Management first reported a position in OLMA in Q3 2023 and has held it in 6 quarters since. The position peaked at $23.8M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Kingdon Capital Management held 1,200,000 shares of Olema Pharmaceuticals worth $15M as of Q2 2026.
  • Kingdon Capital Management bought 345,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $4.62M.
  • Olema Pharmaceuticals made up 1.54% of Kingdon Capital Management's portfolio in Q2 2026, its #21 holding.
  • Kingdon Capital Management first reported a position in Olema Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • Kingdon Capital Management's Olema Pharmaceuticals position peaked at $23.8M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Kingdon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.